Search results
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
Zacks via Yahoo Finance· 2 days agoLooking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the SPDR S&P Biotech ETF (XBI ...
Finding Opportunity in Unloved Healthcare ETFs | ETF Trends
ETF Trends· 11 hours agoSelect Sector Healthcare (XLV) is up only about 4.5%, delivering less than half the returns of the...
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
InvestorPlace· 2 days agoBiotech stocks are not for the faint of heart. Between juggling FDA approvals, new product pipelines...
Cathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock By Investing.com
Investing.com· 21 hours agoCathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
Motley Fool via Yahoo Finance· 3 days agoIf Ginkgo can make the concept work profitably at scale, it will be the first, largest, and most ...
SageView Advisory Group LLC Invests $327,000 in Dimensional U.S. Targeted Value ETF (NYSEARCA:DFAT)
ETF DAILY NEWS· 4 days agoSageView Advisory Group LLC bought a new position in shares of Dimensional U.S. Targeted Value ETF (NYSEARCA:DFAT – Free Report) during the 4th quarter, Holdings Channel reports ...
iShares Latin America 40 ETF (NYSEARCA:ILF) Shares Purchased by Wells Fargo & Company MN
ETF DAILY NEWS· 6 days agoWells Fargo & Company MN boosted its position in iShares Latin America 40 ETF (NYSEARCA:ILF – Free Report) by 137.9% during the fourth quarter, according to its most recent ...
Corient Private Wealth LLC Acquires 5,862 Shares of Vanguard Long-Term Corporate Bond ETF...
ETF DAILY NEWS· 17 hours agoCorient Private Wealth LLC raised its holdings in Vanguard Long-Term Corporate Bond ETF (NASDAQ:VCLT – Free Report) by 27.7% in the fourth quarter, according to its most recent ...
Zacks Investment Ideas feature highlights: RUMIC, Innodata, HF Foods, CSP, Frequency Electronics and...
Zacks via Yahoo Finance· 1 day agoAnd the market perception of their sensitivity to interest rates appears alive and well. But we...
Ocugen stock price analysis: good progress but a risky pattern forms | Invezz
Invezz· 2 days agoOcugen (NASDAQ: OCGN) stock price is doing well this year as investors focus on its ongoing drug...